A carregar...
Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity
Damage to the heart can result from both traditional chemotherapeutic agents, such as doxorubicin, and newer ‘targeted’ therapies, such as trastuzumab. This chemotherapeutic cardiotoxicity is potentially life-threatening and necessitates limiting or discontinuing an otherwise-effective cancer treatm...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3582022/ https://ncbi.nlm.nih.gov/pubmed/23327580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs.12.205 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|